<DOC>
	<DOCNO>NCT01869985</DOCNO>
	<brief_summary>The purpose study evaluate pharmacokinetics safety oral administration HCP1104 Eperisone Hydrochloride plus Aceclofenac .</brief_summary>
	<brief_title>Partial Replicated Crossover Clinical Study Compare Pharmacokinectic Characteristics Eperisone Hydrochloride Aceclofenac With HCP1104 Treatment Those Co-administration Eperisone Hydrochloride 50mg Tablet Aceclofenac 100mg Tablet Healthy Adult Male Volunteers</brief_title>
	<detailed_description>The purpose study evaluate pharmacokinetics safety oral administration HCP1104 Eperisone Hydrochloride plus Aceclofenac .</detailed_description>
	<mesh_term>Aceclofenac</mesh_term>
	<mesh_term>Diclofenac</mesh_term>
	<mesh_term>Eperisone</mesh_term>
	<criteria>Healthy male volunteer , age 20 45 BMI ＞20kg/m2 ＜28kg/m2 subject Informed investigational nature study voluntarily agree participate study Use prescription medication within 14 day prior Day 1 Use medication within 7 day prior Day 1 Participation another clinical study within 60 day prior start study drug administration</criteria>
	<gender>Male</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>45 Years</maximum_age>
	<verification_date>March 2014</verification_date>
	<keyword>HCP1104</keyword>
	<keyword>Eperisone Hydrochloride</keyword>
	<keyword>Aceclofenac</keyword>
</DOC>